ID   PA24C_HUMAN             Reviewed;         541 AA.
AC   Q9UP65; B2RB71; B4DI40; O75457; Q6IBI8; Q9UG68;
DT   10-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 2.
DT   15-MAR-2017, entry version 133.
DE   RecName: Full=Cytosolic phospholipase A2 gamma;
DE            Short=cPLA2-gamma;
DE            EC=3.1.1.4;
DE   AltName: Full=Phospholipase A2 group IVC;
DE   Flags: Precursor;
GN   Name=PLA2G4C;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHARACTERIZATION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9705332; DOI=10.1074/jbc.273.34.21926;
RA   Underwood K.W., Song C., Kriz R.W., Chang X.J., Knopf J.L., Lin L.L.;
RT   "A novel calcium-independent phospholipase A2, cPLA2-gamma, that is
RT   prenylated and contains homology to cPLA2.";
RL   J. Biol. Chem. 273:21926-21932(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, MUTAGENESIS OF
RP   ARG-54; SER-82; ASP-385 AND ARG-402, AND VARIANT PRO-203.
RX   PubMed=10085124; DOI=10.1074/jbc.274.13.8823;
RA   Pickard R.T., Strifler B.A., Kramer R.M., Sharp J.D.;
RT   "Molecular cloning of two new human paralogs of 85-kDa cytosolic
RT   phospholipase A2.";
RL   J. Biol. Chem. 274:8823-8831(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS LYS-21; PRO-38;
RP   VAL-127; PHE-142; VAL-143; GLY-148; LEU-151; PRO-203; SER-226; PRO-360
RP   AND ASN-411.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), AND
RP   VARIANTS VAL-143 AND PRO-203.
RC   TISSUE=Corpus callosum, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   PRO-203.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J.,
RA   Lamerdin J.E., Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M.,
RA   Aerts A., Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E.,
RA   Caenepeel S., Carrano A.V., Caoile C., Chan Y.M., Christensen M.,
RA   Cleland C.A., Copeland A., Dalin E., Dehal P., Denys M., Detter J.C.,
RA   Escobar J., Flowers D., Fotopulos D., Garcia C., Georgescu A.M.,
RA   Glavina T., Gomez M., Gonzales E., Groza M., Hammon N., Hawkins T.,
RA   Haydu L., Ho I., Huang W., Israni S., Jett J., Kadner K., Kimball H.,
RA   Kobayashi A., Larionov V., Leem S.-H., Lopez F., Lou Y., Lowry S.,
RA   Malfatti S., Martinez D., McCready P.M., Medina C., Morgan J.,
RA   Nelson K., Nolan M., Ovcharenko I., Pitluck S., Pollard M.,
RA   Popkie A.P., Predki P., Quan G., Ramirez L., Rash S., Retterer J.,
RA   Rodriguez A., Rogers S., Salamov A., Salazar A., She X., Smith D.,
RA   Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., Ustaszewska A.,
RA   Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., Dubchak I.,
RA   Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 420-476, AND VARIANT CYS-430.
RA   Koyama K.S., Kimura T., Imai T.;
RT   "SNP search of PLA2G4C gene.";
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 443-541 (ISOFORM 1).
RC   TISSUE=Uterus;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [11]
RP   ISOPRENYLATION AT CYS-538, AND METHYLATION AT CYS-538.
RX   PubMed=14529291; DOI=10.1021/bi034611q;
RA   Jenkins C.M., Han X., Yang J., Mancuso D.J., Sims H.F., Muslin A.J.,
RA   Gross R.W.;
RT   "Purification of recombinant human cPLA2 gamma and identification of
RT   C-terminal farnesylation, proteolytic processing, and
RT   carboxymethylation by MALDI-TOF-TOF analysis.";
RL   Biochemistry 42:11798-11807(2003).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-337, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Has a preference for arachidonic acid at the sn-2
CC       position of phosphatidylcholine as compared with palmitic acid.
CC       {ECO:0000269|PubMed:10085124}.
CC   -!- CATALYTIC ACTIVITY: Phosphatidylcholine + H(2)O = 1-
CC       acylglycerophosphocholine + a carboxylate.
CC   -!- ENZYME REGULATION: Not regulated by calcium.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         Vmax=218 pmol/min/mg enzyme {ECO:0000269|PubMed:10085124};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:10085124};
CC       Lipid-anchor {ECO:0000269|PubMed:10085124}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9UP65-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UP65-2; Sequence=VSP_045850;
CC       Name=3;
CC         IsoId=Q9UP65-3; Sequence=VSP_045849;
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart and skeletal muscle.
CC       {ECO:0000269|PubMed:10085124, ECO:0000269|PubMed:9705332}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pla2g4c/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF058921; AAC32823.1; -; mRNA.
DR   EMBL; AF065214; AAC78835.1; -; mRNA.
DR   EMBL; AY485310; AAR25453.1; -; Genomic_DNA.
DR   EMBL; AK295400; BAG58352.1; -; mRNA.
DR   EMBL; AK314524; BAG37118.1; -; mRNA.
DR   EMBL; CR456816; CAG33097.1; -; mRNA.
DR   EMBL; AC010458; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC011466; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471177; EAW52314.1; -; Genomic_DNA.
DR   EMBL; BC063416; AAH63416.1; -; mRNA.
DR   EMBL; AB105807; BAC87745.1; -; Genomic_DNA.
DR   EMBL; AL050193; CAB43312.3; -; mRNA.
DR   CCDS; CCDS12710.1; -. [Q9UP65-1]
DR   CCDS; CCDS54286.1; -. [Q9UP65-2]
DR   CCDS; CCDS59403.1; -. [Q9UP65-3]
DR   PIR; T13162; T13162.
DR   RefSeq; NP_001152794.1; NM_001159322.1. [Q9UP65-3]
DR   RefSeq; NP_001152795.1; NM_001159323.1. [Q9UP65-2]
DR   RefSeq; NP_003697.2; NM_003706.2. [Q9UP65-1]
DR   UniGene; Hs.631562; -.
DR   ProteinModelPortal; Q9UP65; -.
DR   BioGrid; 114165; 3.
DR   STRING; 9606.ENSP00000400036; -.
DR   BindingDB; Q9UP65; -.
DR   ChEMBL; CHEMBL4834; -.
DR   SwissLipids; SLP:000000888; -.
DR   SwissLipids; SLP:000001081; -. [Q9UP65-1]
DR   iPTMnet; Q9UP65; -.
DR   PhosphoSitePlus; Q9UP65; -.
DR   SwissPalm; Q9UP65; -.
DR   BioMuta; PLA2G4C; -.
DR   DMDM; 322510066; -.
DR   PaxDb; Q9UP65; -.
DR   PeptideAtlas; Q9UP65; -.
DR   PRIDE; Q9UP65; -.
DR   Ensembl; ENST00000354276; ENSP00000346228; ENSG00000105499. [Q9UP65-2]
DR   Ensembl; ENST00000599111; ENSP00000472546; ENSG00000105499. [Q9UP65-3]
DR   Ensembl; ENST00000599921; ENSP00000469473; ENSG00000105499. [Q9UP65-1]
DR   GeneID; 8605; -.
DR   KEGG; hsa:8605; -.
DR   UCSC; uc002phx.4; human. [Q9UP65-1]
DR   CTD; 8605; -.
DR   DisGeNET; 8605; -.
DR   GeneCards; PLA2G4C; -.
DR   HGNC; HGNC:9037; PLA2G4C.
DR   HPA; HPA043083; -.
DR   MIM; 603602; gene.
DR   neXtProt; NX_Q9UP65; -.
DR   OpenTargets; ENSG00000105499; -.
DR   PharmGKB; PA33365; -.
DR   eggNOG; KOG1325; Eukaryota.
DR   eggNOG; ENOG410XR72; LUCA.
DR   GeneTree; ENSGT00550000074489; -.
DR   HOGENOM; HOG000059624; -.
DR   HOVERGEN; HBG058910; -.
DR   InParanoid; Q9UP65; -.
DR   KO; K16342; -.
DR   OMA; LFNIDAC; -.
DR   OrthoDB; EOG091G04R7; -.
DR   PhylomeDB; Q9UP65; -.
DR   TreeFam; TF325228; -.
DR   Reactome; R-HSA-1482788; Acyl chain remodelling of PC.
DR   Reactome; R-HSA-1482839; Acyl chain remodelling of PE.
DR   Reactome; R-HSA-1482922; Acyl chain remodelling of PI.
DR   Reactome; R-HSA-1483115; Hydrolysis of LPC.
DR   Reactome; R-HSA-1483152; Hydrolysis of LPE.
DR   GeneWiki; PLA2G4C; -.
DR   GenomeRNAi; 8605; -.
DR   PRO; PR:Q9UP65; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105499; -.
DR   CleanEx; HS_PLA2G4C; -.
DR   ExpressionAtlas; Q9UP65; baseline and differential.
DR   Genevisible; Q9UP65; HS.
DR   GO; GO:0005938; C:cell cortex; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:UniProtKB.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; TAS:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0047499; F:calcium-independent phospholipase A2 activity; IDA:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; TAS:Reactome.
DR   GO; GO:0008970; F:phosphatidylcholine 1-acylhydrolase activity; TAS:Reactome.
DR   GO; GO:0004623; F:phospholipase A2 activity; TAS:Reactome.
DR   GO; GO:0005543; F:phospholipid binding; NAS:UniProtKB.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; NAS:UniProtKB.
DR   GO; GO:0046475; P:glycerophospholipid catabolic process; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; NAS:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; NAS:UniProtKB.
DR   GO; GO:0007567; P:parturition; NAS:UniProtKB.
DR   GO; GO:0036151; P:phosphatidylcholine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036152; P:phosphatidylethanolamine acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0036149; P:phosphatidylinositol acyl-chain remodeling; TAS:Reactome.
DR   GO; GO:0006644; P:phospholipid metabolic process; TAS:UniProtKB.
DR   InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR   InterPro; IPR002642; LysoPLipase_cat_dom.
DR   Pfam; PF01735; PLA2_B; 1.
DR   SMART; SM00022; PLAc; 1.
DR   SUPFAM; SSF52151; SSF52151; 1.
DR   PROSITE; PS51210; PLA2C; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Lipoprotein; Membrane; Methylation; Phosphoprotein;
KW   Polymorphism; Prenylation; Reference proteome.
FT   CHAIN         1    538       Cytosolic phospholipase A2 gamma.
FT                                /FTId=PRO_0000022995.
FT   PROPEP      539    541       Removed in mature form.
FT                                /FTId=PRO_0000022996.
FT   DOMAIN        1    541       PLA2c. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00555}.
FT   ACT_SITE     82     82       Nucleophile. {ECO:0000250}.
FT   ACT_SITE    385    385       Proton acceptor. {ECO:0000250}.
FT   MOD_RES     337    337       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     538    538       Cysteine methyl ester.
FT                                {ECO:0000269|PubMed:14529291}.
FT   LIPID       538    538       S-farnesyl cysteine.
FT                                {ECO:0000269|PubMed:14529291}.
FT   VAR_SEQ       1     13       MGSSEVSIIPGLQ -> MRTRPRPRLRRTENFLTAVHHGK
FT                                (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045849.
FT   VAR_SEQ     528    541       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_045850.
FT   VARIANT      21     21       E -> K (in dbSNP:rs11564522).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018761.
FT   VARIANT      38     38       A -> P (in dbSNP:rs2307279).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018420.
FT   VARIANT     127    127       A -> V (in dbSNP:rs11564532).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018762.
FT   VARIANT     142    142       V -> F (in dbSNP:rs11564534).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018763.
FT   VARIANT     143    143       I -> V (in dbSNP:rs2303744).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018421.
FT   VARIANT     148    148       R -> G (in dbSNP:rs2307282).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018764.
FT   VARIANT     151    151       P -> L (in dbSNP:rs11564538).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018765.
FT   VARIANT     203    203       S -> P (in dbSNP:rs156631).
FT                                {ECO:0000269|PubMed:10085124,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|Ref.3, ECO:0000269|Ref.5}.
FT                                /FTId=VAR_018422.
FT   VARIANT     226    226       T -> S (in dbSNP:rs11564541).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018766.
FT   VARIANT     360    360       T -> P (in dbSNP:rs11564620).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018767.
FT   VARIANT     411    411       D -> N (in dbSNP:rs11564638).
FT                                {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018768.
FT   VARIANT     430    430       R -> C (in dbSNP:rs191276960).
FT                                {ECO:0000269|Ref.9}.
FT                                /FTId=VAR_018423.
FT   MUTAGEN      54     54       R->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10085124}.
FT   MUTAGEN      82     82       S->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10085124}.
FT   MUTAGEN     385    385       D->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10085124}.
FT   MUTAGEN     402    402       R->A: Abolishes enzyme activity.
FT                                {ECO:0000269|PubMed:10085124}.
FT   CONFLICT     24     24       R -> G (in Ref. 4; BAG58352).
FT                                {ECO:0000305}.
FT   CONFLICT    465    465       M -> I (in Ref. 1; AAC32823).
FT                                {ECO:0000305}.
FT   CONFLICT    480    480       E -> G (in Ref. 5; CAG33097).
FT                                {ECO:0000305}.
SQ   SEQUENCE   541 AA;  60939 MW;  A114B2A614EA4632 CRC64;
     MGSSEVSIIP GLQKEEKAAV ERRRLHVLKA LKKLRIEADE APVVAVLGSG GGLRAHIACL
     GVLSEMKEQG LLDAVTYLAG VSGSTWAISS LYTNDGDMEA LEADLKHRFT RQEWDLAKSL
     QKTIQAARSE NYSLTDFWAY MVISKQTREL PESHLSNMKK PVEEGTLPYP IFAAIDNDLQ
     PSWQEARAPE TWFEFTPHHA GFSALGAFVS ITHFGSKFKK GRLVRTHPER DLTFLRGLWG
     SALGNTEVIR EYIFDQLRNL TLKGLWRRAV ANAKSIGHLI FARLLRLQES SQGEHPPPED
     EGGEPEHTWL TEMLENWTRT SLEKQEQPHE DPERKGSLSN LMDFVKKTGI CASKWEWGTT
     HNFLYKHGGI RDKIMSSRKH LHLVDAGLAI NTPFPLVLPP TREVHLILSF DFSAGDPFET
     IRATTDYCRR HKIPFPQVEE AELDLWSKAP ASCYILKGET GPVVMHFPLF NIDACGGDIE
     AWSDTYDTFK LADTYTLDVV VLLLALAKKN VRENKKKILR ELMNVAGLYY PKDSARSCCL
     A
//
